JP2014509195A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014509195A5 JP2014509195A5 JP2013555596A JP2013555596A JP2014509195A5 JP 2014509195 A5 JP2014509195 A5 JP 2014509195A5 JP 2013555596 A JP2013555596 A JP 2013555596A JP 2013555596 A JP2013555596 A JP 2013555596A JP 2014509195 A5 JP2014509195 A5 JP 2014509195A5
- Authority
- JP
- Japan
- Prior art keywords
- talen
- embryo
- cell
- gene
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000010459 TALEN Methods 0.000 claims description 70
- 108010043645 Transcription Activator-Like Effector Nucleases Proteins 0.000 claims description 70
- 210000004027 cell Anatomy 0.000 claims description 44
- 238000000034 method Methods 0.000 claims description 37
- 238000012217 deletion Methods 0.000 claims description 31
- 230000037430 deletion Effects 0.000 claims description 31
- 108700028369 Alleles Proteins 0.000 claims description 25
- 241001465754 Metazoa Species 0.000 claims description 23
- 239000002773 nucleotide Substances 0.000 claims description 23
- 125000003729 nucleotide group Chemical group 0.000 claims description 23
- 108090000623 proteins and genes Proteins 0.000 claims description 23
- 210000001161 mammalian embryo Anatomy 0.000 claims description 22
- 244000144972 livestock Species 0.000 claims description 17
- 238000003780 insertion Methods 0.000 claims description 16
- 230000037431 insertion Effects 0.000 claims description 16
- 241000282898 Sus scrofa Species 0.000 claims description 14
- 241000283690 Bos taurus Species 0.000 claims description 12
- 238000010362 genome editing Methods 0.000 claims description 9
- 230000000694 effects Effects 0.000 claims description 8
- 210000002257 embryonic structure Anatomy 0.000 claims description 8
- 230000008685 targeting Effects 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 5
- 238000012239 gene modification Methods 0.000 claims description 5
- 239000013612 plasmid Substances 0.000 claims description 5
- 102000054765 polymorphisms of proteins Human genes 0.000 claims description 5
- 238000000338 in vitro Methods 0.000 claims description 4
- 108020004999 messenger RNA Proteins 0.000 claims description 4
- 210000002459 blastocyst Anatomy 0.000 claims description 3
- 238000010367 cloning Methods 0.000 claims description 3
- 239000003550 marker Substances 0.000 claims description 3
- 230000006798 recombination Effects 0.000 claims description 3
- 238000005215 recombination Methods 0.000 claims description 3
- 238000012546 transfer Methods 0.000 claims description 3
- 238000010374 somatic cell nuclear transfer Methods 0.000 claims description 2
- 150000007523 nucleic acids Chemical class 0.000 claims 6
- 210000000130 stem cell Anatomy 0.000 claims 6
- 102000018120 Recombinases Human genes 0.000 claims 5
- 108010091086 Recombinases Proteins 0.000 claims 5
- 108020004707 nucleic acids Proteins 0.000 claims 5
- 102000039446 nucleic acids Human genes 0.000 claims 5
- 108010017070 Zinc Finger Nucleases Proteins 0.000 claims 4
- 108091033319 polynucleotide Proteins 0.000 claims 3
- 102000040430 polynucleotide Human genes 0.000 claims 3
- 239000002157 polynucleotide Substances 0.000 claims 3
- 230000005017 genetic modification Effects 0.000 claims 2
- 235000013617 genetically modified food Nutrition 0.000 claims 2
- 241000251468 Actinopterygii Species 0.000 claims 1
- 241000283707 Capra Species 0.000 claims 1
- 108010077544 Chromatin Proteins 0.000 claims 1
- 241000287828 Gallus gallus Species 0.000 claims 1
- 230000010558 Gene Alterations Effects 0.000 claims 1
- 102000004472 Myostatin Human genes 0.000 claims 1
- 108010056852 Myostatin Proteins 0.000 claims 1
- 241000283973 Oryctolagus cuniculus Species 0.000 claims 1
- 241001494479 Pecora Species 0.000 claims 1
- 241000282887 Suidae Species 0.000 claims 1
- 241001493546 Suina Species 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 238000004113 cell culture Methods 0.000 claims 1
- 235000013330 chicken meat Nutrition 0.000 claims 1
- 210000003483 chromatin Anatomy 0.000 claims 1
- 239000013611 chromosomal DNA Substances 0.000 claims 1
- 238000012136 culture method Methods 0.000 claims 1
- 210000004602 germ cell Anatomy 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 210000001082 somatic cell Anatomy 0.000 claims 1
- 238000003786 synthesis reaction Methods 0.000 claims 1
- 230000035772 mutation Effects 0.000 description 15
- 108020004414 DNA Proteins 0.000 description 7
- 210000002950 fibroblast Anatomy 0.000 description 7
- 238000003556 assay Methods 0.000 description 6
- 102000000853 LDL receptors Human genes 0.000 description 5
- 108010001831 LDL receptors Proteins 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 108091093088 Amplicon Proteins 0.000 description 4
- 101710163270 Nuclease Proteins 0.000 description 4
- 230000011559 double-strand break repair via nonhomologous end joining Effects 0.000 description 4
- 230000004927 fusion Effects 0.000 description 4
- 238000012163 sequencing technique Methods 0.000 description 4
- 230000027455 binding Effects 0.000 description 3
- BRZYSWJRSDMWLG-CAXSIQPQSA-N geneticin Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](C(C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-CAXSIQPQSA-N 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 238000001890 transfection Methods 0.000 description 3
- 108700024394 Exon Proteins 0.000 description 2
- 102100039939 Growth/differentiation factor 8 Human genes 0.000 description 2
- 101000886562 Homo sapiens Growth/differentiation factor 8 Proteins 0.000 description 2
- 108010025815 Kanamycin Kinase Proteins 0.000 description 2
- 101150013552 LDLR gene Proteins 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000710 homodimer Substances 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 1
- 101100228731 Bos taurus MSTN gene Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 230000007018 DNA scission Effects 0.000 description 1
- 230000004568 DNA-binding Effects 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 238000010222 PCR analysis Methods 0.000 description 1
- 238000002944 PCR assay Methods 0.000 description 1
- 102000008579 Transposases Human genes 0.000 description 1
- 108010020764 Transposases Proteins 0.000 description 1
- 238000007844 allele-specific PCR Methods 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 238000012761 co-transfection Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000000326 densiometry Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 230000037433 frameshift Effects 0.000 description 1
- 238000013412 genome amplification Methods 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000005937 nuclear translocation Effects 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 230000024540 transposon integration Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161446651P | 2011-02-25 | 2011-02-25 | |
| US61/446,651 | 2011-02-25 | ||
| PCT/US2012/026500 WO2012116274A2 (en) | 2011-02-25 | 2012-02-24 | Genetically modified animals and methods for making the same |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017093111A Division JP2017184744A (ja) | 2011-02-25 | 2017-05-09 | 遺伝子改変動物、およびそれを作製する方法 |
| JP2017093110A Division JP2017184743A (ja) | 2011-02-25 | 2017-05-09 | 遺伝子改変動物、およびそれを作製する方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014509195A JP2014509195A (ja) | 2014-04-17 |
| JP2014509195A5 true JP2014509195A5 (enExample) | 2015-04-09 |
Family
ID=46719944
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013555596A Pending JP2014509195A (ja) | 2011-02-25 | 2012-02-24 | 遺伝子改変動物、およびそれを作製する方法 |
| JP2017093111A Pending JP2017184744A (ja) | 2011-02-25 | 2017-05-09 | 遺伝子改変動物、およびそれを作製する方法 |
| JP2017093110A Pending JP2017184743A (ja) | 2011-02-25 | 2017-05-09 | 遺伝子改変動物、およびそれを作製する方法 |
| JP2019152894A Pending JP2020010692A (ja) | 2011-02-25 | 2019-08-23 | 遺伝子改変動物、およびそれを作製する方法 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017093111A Pending JP2017184744A (ja) | 2011-02-25 | 2017-05-09 | 遺伝子改変動物、およびそれを作製する方法 |
| JP2017093110A Pending JP2017184743A (ja) | 2011-02-25 | 2017-05-09 | 遺伝子改変動物、およびそれを作製する方法 |
| JP2019152894A Pending JP2020010692A (ja) | 2011-02-25 | 2019-08-23 | 遺伝子改変動物、およびそれを作製する方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US20120222143A1 (enExample) |
| EP (3) | EP3450563A1 (enExample) |
| JP (4) | JP2014509195A (enExample) |
| KR (1) | KR20140046408A (enExample) |
| CN (4) | CN107090470B (enExample) |
| AR (1) | AR085507A1 (enExample) |
| AU (3) | AU2012222144B2 (enExample) |
| BR (1) | BR112013021785A8 (enExample) |
| CA (1) | CA2828239C (enExample) |
| CL (1) | CL2013002438A1 (enExample) |
| EA (1) | EA201391234A1 (enExample) |
| MX (2) | MX363013B (enExample) |
| WO (1) | WO2012116274A2 (enExample) |
Families Citing this family (75)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011053982A2 (en) | 2009-11-02 | 2011-05-05 | University Of Washington | Therapeutic nuclease compositions and methods |
| BR112012020257A8 (pt) * | 2010-02-11 | 2018-02-14 | Recombinetics Inc | métodos e aparelhos para produzir artiodátilos transgênicos |
| US10920242B2 (en) | 2011-02-25 | 2021-02-16 | Recombinetics, Inc. | Non-meiotic allele introgression |
| US9528124B2 (en) * | 2013-08-27 | 2016-12-27 | Recombinetics, Inc. | Efficient non-meiotic allele introgression |
| JP6063450B2 (ja) | 2011-04-29 | 2017-01-18 | ユニヴァーシティ オブ ワシントン | 治療用ヌクレアーゼ組成物および方法 |
| US8497124B2 (en) * | 2011-12-05 | 2013-07-30 | Factor Bioscience Inc. | Methods and products for reprogramming cells to a less differentiated state |
| US9179935B2 (en) * | 2012-01-13 | 2015-11-10 | The Board Of Trustees Of The Leland Stanford Junior University | Mechanical biomarkers for oocyte and embryo viability |
| AU2013204327B2 (en) * | 2012-04-20 | 2016-09-01 | Aviagen | Cell transfection method |
| CA3133545C (en) * | 2012-05-25 | 2023-08-08 | Cellectis | Use of pre t alpha or functional variant thereof for expanding tcr alpha deficient t cells |
| AR091482A1 (es) * | 2012-06-21 | 2015-02-04 | Recombinetics Inc | Celulas modificadas geneticamente y metodos par su obtencion |
| WO2013191769A1 (en) * | 2012-06-22 | 2013-12-27 | Mayo Foundation For Medical Education And Research | Genome editing |
| US10058078B2 (en) | 2012-07-31 | 2018-08-28 | Recombinetics, Inc. | Production of FMDV-resistant livestock by allele substitution |
| GB201216564D0 (en) * | 2012-09-17 | 2012-10-31 | Univ Edinburgh | Genetically edited animal |
| CA2889502A1 (en) * | 2012-10-30 | 2014-05-08 | Recombinetics, Inc. | Control of sexual maturation in animals |
| BR122019025681B1 (pt) * | 2012-11-01 | 2023-04-18 | Factor Bioscience Inc | Método para inserir uma sequência de ácido nucleico em uma localização segura de um genoma de uma célula |
| CN102964431B (zh) * | 2012-12-03 | 2014-05-07 | 中国农业科学院北京畜牧兽医研究所 | 一对特异识别肌肉生长抑制素基因的多肽及其编码基因和应用 |
| US9708589B2 (en) | 2012-12-18 | 2017-07-18 | Monsanto Technology Llc | Compositions and methods for custom site-specific DNA recombinases |
| WO2014110552A1 (en) * | 2013-01-14 | 2014-07-17 | Recombinetics, Inc. | Hornless livestock |
| US10793867B2 (en) | 2013-03-15 | 2020-10-06 | Monsanto Technology, Llc | Methods for targeted transgene-integration using custom site-specific DNA recombinases |
| US11039586B2 (en) | 2013-03-15 | 2021-06-22 | Monsanto Technology Llc | Creation and transmission of megaloci |
| EP2994531B1 (en) * | 2013-05-10 | 2018-03-28 | Sangamo Therapeutics, Inc. | Delivery methods and compositions for nuclease-mediated genome engineering |
| US11077144B2 (en) | 2013-05-13 | 2021-08-03 | Cellectis | CD19 specific chimeric antigen receptor and uses thereof |
| US20140359795A1 (en) * | 2013-05-31 | 2014-12-04 | Recombinetics, Inc. | Genetic techniques for making animals with sortable sperm |
| US20140359796A1 (en) * | 2013-05-31 | 2014-12-04 | Recombinetics, Inc. | Genetically sterile animals |
| US9982277B2 (en) | 2013-06-11 | 2018-05-29 | The Regents Of The University Of California | Methods and compositions for target DNA modification |
| PL3033184T3 (pl) | 2013-08-16 | 2021-09-20 | Massachusetts Institute Of Technology | Selektywne dostarczanie materiału do komórek |
| WO2015035034A1 (en) * | 2013-09-04 | 2015-03-12 | Mice With Horns, Llc | Materials and methods for correcting recessive mutations in animals |
| DE102013111099B4 (de) | 2013-10-08 | 2023-11-30 | Eberhard Karls Universität Tübingen Medizinische Fakultät | Permanente Genkorrektur mittels nukleotidmodifizierter messenger RNA |
| EP3060682B1 (en) | 2013-10-25 | 2023-08-30 | Livestock Improvement Corporation Limited | Genetic markers and uses therefor |
| HRP20192080T1 (hr) | 2013-10-31 | 2020-02-07 | Resolve Therapeutics, Llc | Terapeutske fuzije nukleaza-albumine i postupci |
| KR101554166B1 (ko) | 2013-11-13 | 2015-09-22 | 건국대학교 산학협력단 | 재조합 활성 유전자 2 유전자 적중벡터, 그 벡터가 도입된 면역세포 결핍 형질전환 미니 복제돼지 생산과 그 제조방법 및 활용 |
| KR101566498B1 (ko) | 2013-11-13 | 2015-11-06 | 건국대학교 산학협력단 | 인터루킨 2 수용체 감마 유전자 적중벡터, 그 벡터가 도입된 면역세포 결핍 형질전환 미니 복제돼지 생산과 그 제조방법 및 활용 |
| DK3492593T3 (da) * | 2013-11-13 | 2021-11-08 | Childrens Medical Center | Nukleasemedieret regulering af genekspression |
| CN103952424B (zh) * | 2014-04-23 | 2017-01-11 | 尹熙俊 | 生产mstn双侧基因敲除的双肌性状体细胞克隆猪的方法 |
| MX2016014066A (es) * | 2014-04-28 | 2017-05-03 | Recombinetics Inc | Edicion de genes multiples en cerdos. |
| CN103952405B (zh) * | 2014-05-13 | 2016-02-10 | 扬州大学 | 一种山羊mstn基因定点修饰系统及其应用 |
| MX2017003770A (es) | 2014-09-23 | 2017-06-30 | Aggenetics Inc | Materiales y metodos para la produccion de animales con pelo corto. |
| JP7523203B2 (ja) | 2014-10-31 | 2024-07-26 | マサチューセッツ インスティテュート オブ テクノロジー | 生体分子の免疫細胞への送達 |
| HK1242917A1 (zh) * | 2014-11-12 | 2018-07-06 | 重组股份有限公司 | 肿瘤抑制基因的杂合修饰和1型神经纤维瘤病的猪模型 |
| CN104450673B (zh) * | 2014-11-14 | 2017-07-21 | 中国农业大学 | 一种y染色体修饰方法及其应用 |
| CN104388560B (zh) * | 2014-11-14 | 2017-04-12 | 中国农业大学 | 一种y染色体标记方法及其应用 |
| US20180105834A1 (en) * | 2014-11-27 | 2018-04-19 | Institute Of Animal Sciences, Chinese Academy Of Agrigultural Sciences | A method of site-directed insertion to h11 locus in pigs by using site-directed cutting system |
| KR101724805B1 (ko) * | 2014-12-16 | 2017-04-11 | 서울대학교산학협력단 | 유전자 적중 물질을 이용한 조류 유전자 편집방법 및 유전자 편집 조류 |
| EP3245294A4 (en) | 2015-01-12 | 2018-05-30 | Massachusetts Institute of Technology | Gene editing through microfluidic delivery |
| EP3316898A4 (en) * | 2015-06-30 | 2019-02-27 | Regents of the University of Minnesota | HUMANIZED SKELETON MUSCLE |
| JP6925984B2 (ja) | 2015-07-09 | 2021-08-25 | マサチューセッツ インスティテュート オブ テクノロジー | 無核細胞への物質の送達 |
| US11339408B2 (en) | 2015-08-20 | 2022-05-24 | Applied Stemcell, Inc. | Nuclease with enhanced efficiency of genome editing |
| WO2017041051A1 (en) | 2015-09-04 | 2017-03-09 | Sqz Biotechnologies Company | Intracellular delivery of biomolecules to cells comprising a cell wall |
| EP3673732A3 (en) | 2015-10-27 | 2020-07-29 | Recombinetics, Inc. | Engineering of humanized car t-cells and platelets by genetic complementation |
| ES3040945T3 (en) * | 2015-10-28 | 2025-11-06 | Vertex Pharma | Materials and methods for treatment of duchenne muscular dystrophy |
| CN105543257A (zh) * | 2016-01-18 | 2016-05-04 | 安徽农业大学 | 一种pAPN基因定点修饰猪 |
| KR20230110373A (ko) * | 2016-06-14 | 2023-07-21 | 리전츠 오브 더 유니버스티 오브 미네소타 | 질환을 치료하기 위한 유전적으로 변형된 세포, 조직,및 장기 |
| CA3028074A1 (en) * | 2016-06-16 | 2018-12-20 | Oslo Universitetssykehus Hf | Improved gene editing |
| DK3478830T3 (da) | 2016-07-01 | 2024-05-21 | Resolve Therapeutics Llc | Optimerede binucleasefusioner og metoder |
| US20180084767A1 (en) | 2016-09-21 | 2018-03-29 | Recombinetics, Inc. | Animal models for cardiomyopathy |
| GB201617559D0 (en) | 2016-10-17 | 2016-11-30 | University Court Of The University Of Edinburgh The | Swine comprising modified cd163 and associated methods |
| WO2018144087A2 (en) * | 2016-11-03 | 2018-08-09 | Temple University-Of The Commonwealth System Of Higher Education | Dna plasmids for the fast generation of homologous recombination vectors for cell line development |
| CA3057159A1 (en) | 2017-04-12 | 2018-10-18 | Magenta Therapeutics Inc. | Aryl hydrocarbon receptor antagonists and uses thereof |
| CN108728477B (zh) * | 2017-04-24 | 2022-02-22 | 华东理工大学 | 一种高效的转座突变系统及构建方法 |
| EP3665279B1 (en) * | 2017-08-09 | 2023-07-19 | Benson Hill, Inc. | Compositions and methods for modifying genomes |
| US20190045761A1 (en) | 2017-08-11 | 2019-02-14 | Recombinetics, Inc. | Inducible disease models methods of making them and use in tissue complementation |
| JP7374091B2 (ja) | 2017-08-22 | 2023-11-06 | サナバイオ， エルエルシー | 可溶性インターフェロン受容体およびその使用 |
| CN111542597A (zh) | 2017-10-31 | 2020-08-14 | 美真达治疗公司 | 用于扩增造血干细胞和祖细胞的组合物和方法 |
| WO2019113375A2 (en) | 2017-12-06 | 2019-06-13 | Magenta Therapeutics, Inc. | Dosing regimens for the mobilization of hematopoietic stem and progenitor cells |
| CN108949830B (zh) * | 2018-08-03 | 2021-11-26 | 福州大学 | 一种在鱼类中实现基因组编辑、精确定点基因敲入的方法 |
| CN111793654B (zh) * | 2019-04-08 | 2022-05-24 | 中国农业大学 | 一种提高CRISPR/Cas9介导的双等位基因突变效率的方法及其应用 |
| WO2020210237A1 (en) * | 2019-04-08 | 2020-10-15 | Dna Twopointo Inc. | Transposition of nucleic acid constructs into eukaryotic genomes with a transposase from amyelois |
| WO2021087406A1 (en) | 2019-11-01 | 2021-05-06 | Magenta Therapeutics, Inc. | Dosing regimens for the mobilization of hematopoietic stem and progentor cells |
| AU2021263754A1 (en) | 2020-04-27 | 2022-12-01 | Ensoma, Inc. | Methods and compositions for transducing hematopoietic stem and progenitor cells in vivo |
| EP4308694A1 (en) | 2021-03-16 | 2024-01-24 | Magenta Therapeutics, Inc. | Dosing regimens for hematopoietic stem cell mobilization for stem cell transplants in multiple myeloma patients |
| GB202118058D0 (en) | 2021-12-14 | 2022-01-26 | Univ Warwick | Methods to increase yields in crops |
| US20250129385A1 (en) * | 2022-02-01 | 2025-04-24 | Abs Global, Inc. | Gene-editing methods for embryonic stem cells |
| GB2621813A (en) | 2022-06-30 | 2024-02-28 | Univ Newcastle | Preventing disease recurrence in Mitochondrial replacement therapy |
| WO2024036106A1 (en) * | 2022-08-08 | 2024-02-15 | The Board Of Trustees Of The Leland Stanford Junior University | Embryo microglia complementation for in vivo microglia manipulation and production of a non-human animal model for validation of gene function and therapeutic screening |
| GB202314578D0 (en) | 2023-09-22 | 2023-11-08 | Univ Manchester | Methods of producing homoplasmic modified plants or parts thereof |
Family Cites Families (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4873191A (en) | 1981-06-12 | 1989-10-10 | Ohio University | Genetic transformation of zygotes |
| US4888274A (en) | 1985-09-18 | 1989-12-19 | Yale University | RecA nucleoprotein filament and methods |
| US5731178A (en) | 1990-03-21 | 1998-03-24 | Behringwerke Aktiengesellschaft | Attachment-elements for stimulation of eukaryotic expression systems |
| US5510473A (en) | 1990-11-09 | 1996-04-23 | The United States Of American As Represented By The Secretary Of Health And Human Services | Cloning of the recA gene from thermus aquaticus YT-1 |
| US5763240A (en) | 1992-04-24 | 1998-06-09 | Sri International | In vivo homologous sequence targeting in eukaryotic cells |
| US5674992A (en) | 1992-08-28 | 1997-10-07 | Cornell Research Foundation, Inc. | CDNA encoding a recA homolog in eukaryotes |
| US5610053A (en) | 1993-04-07 | 1997-03-11 | The United States Of America As Represented By The Department Of Health And Human Services | DNA sequence which acts as a chromatin insulator element to protect expressed genes from cis-acting regulatory sequences in mammalian cells |
| US5731411A (en) | 1993-07-12 | 1998-03-24 | The United States Of America As Represented By The Department Of Health And Human Services | Promotion of homologous DNA pairing by RecA-derived peptides |
| EP0821070A1 (en) | 1996-07-22 | 1998-01-28 | Carelli, Claude Marcel Henri | Pit-1 gene polymorphism and trait selection in animals |
| US6037525A (en) | 1996-08-01 | 2000-03-14 | North Carolina State University | Method for reducing expression variability of transgenes in plant cells |
| US5948653A (en) | 1997-03-21 | 1999-09-07 | Pati; Sushma | Sequence alterations using homologous recombination |
| DE69841139D1 (de) * | 1997-07-14 | 2009-10-22 | Univ Liege | Mutationen im myostatingen steigern muskelmasse in säugetieren |
| US6541684B1 (en) | 1998-02-13 | 2003-04-01 | Trustees Of Columbia University In The City Of New York | Nucleotide sequences encoding maize RAD51 |
| US6388169B1 (en) | 1998-06-08 | 2002-05-14 | Pioneer Hi-Bred International, Inc. | Maize orthologues of bacterial RecA proteins |
| US6774213B1 (en) | 1998-07-24 | 2004-08-10 | Alberto I. Roca | Mutants of MAW motifs of RecA protein homologs, methods of making them, and their uses |
| US6632672B2 (en) | 1998-08-19 | 2003-10-14 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for genomic modification |
| GB2365445A (en) | 1998-10-12 | 2002-02-20 | Geron Bio Med Ltd | Porcine occcytes with improved developmental competence |
| WO2000023606A1 (en) | 1998-10-22 | 2000-04-27 | Medical College Of Georgia Institute, Inc. | Long terminal repeat, enhancer, and insulator sequences for use in recombinant vectors |
| US6720478B1 (en) | 1999-05-05 | 2004-04-13 | Pioneer Hi-Bred International, Inc. | RAD51-like polynucleotide and uses thereof |
| IL146296A0 (en) * | 1999-05-06 | 2002-07-25 | Stem Cell Sciences Pty Ltd | Cell reprogramming |
| AU1100201A (en) | 1999-10-28 | 2001-05-08 | Board Of Trustees Of The Leland Stanford Junior University | Methods of in vivo gene transfer using a sleeping beauty transposon system |
| US6686515B1 (en) | 1999-11-23 | 2004-02-03 | Maxygen, Inc. | Homologous recombination in plants |
| ATE490338T1 (de) | 2000-02-18 | 2010-12-15 | Univ Leland Stanford Junior | Veränderte rekombinasen zur modifizierung des genoms |
| DK1311661T3 (da) | 2000-08-14 | 2012-11-26 | Us Gov Health & Human Serv | Forøget homolog rekombination medieret ved lambda-rekombinationsproteiner |
| AU2002324941A1 (en) | 2001-09-07 | 2003-03-24 | The Regents Of The University Of California | Method of generating a transgenic livestock animal |
| US20030232410A1 (en) * | 2002-03-21 | 2003-12-18 | Monika Liljedahl | Methods and compositions for using zinc finger endonucleases to enhance homologous recombination |
| US7176007B2 (en) | 2002-12-12 | 2007-02-13 | Wisconsin Alumni Research Foundation | RecA mutants |
| CA2512110A1 (en) | 2002-12-31 | 2004-07-22 | Mmi Genomics, Inc. | Compositions, methods, and systems for inferring bovine breed |
| US20040203158A1 (en) | 2003-01-15 | 2004-10-14 | Hackett Perry B. | Transposon-insulator element delivery systems |
| US7985739B2 (en) | 2003-06-04 | 2011-07-26 | The Board Of Trustees Of The Leland Stanford Junior University | Enhanced sleeping beauty transposon system and methods for using the same |
| CA2543786A1 (en) | 2003-10-24 | 2005-05-06 | Mmi Genomics, Inc. | Methods and systems for inferring traits to manage non-beef livestock |
| CA2563064A1 (en) * | 2004-04-22 | 2005-11-10 | Kirin Beer Kabushiki Kaisha | Transgenic animals and uses thereof |
| ES2679282T3 (es) * | 2004-10-22 | 2018-08-23 | Revivicor Inc. | Porcinos transgénicos que carecen de cadena ligera de inmunoglobulina endógena |
| CA2667414C (en) * | 2006-11-13 | 2015-12-29 | Sangamo Biosciences, Inc. | Methods and compositions for modification of the human glucocorticoid receptor locus |
| WO2010008562A2 (en) | 2008-07-16 | 2010-01-21 | Recombinetics | Methods and materials for producing transgenic animals |
| US20100105140A1 (en) | 2008-07-16 | 2010-04-29 | Fahrenkrug Scott C | Plaice dna transposon system |
| KR20160015400A (ko) * | 2008-08-22 | 2016-02-12 | 상가모 바이오사이언스 인코포레이티드 | 표적화된 단일가닥 분할 및 표적화된 통합을 위한 방법 및 조성물 |
| US20110023158A1 (en) * | 2008-12-04 | 2011-01-27 | Sigma-Aldrich Co. | Bovine genome editing with zinc finger nucleases |
| US20110023140A1 (en) | 2008-12-04 | 2011-01-27 | Sigma-Aldrich Co. | Rabbit genome editing with zinc finger nucleases |
| EP2206723A1 (en) * | 2009-01-12 | 2010-07-14 | Bonas, Ulla | Modular DNA-binding domains |
| US20120149115A1 (en) * | 2009-06-11 | 2012-06-14 | Snu R&Db Foundation | Targeted genomic rearrangements using site-specific nucleases |
| JP2013500018A (ja) * | 2009-07-24 | 2013-01-07 | シグマ−アルドリッチ・カンパニー・リミテッド・ライアビリティ・カンパニー | ゲノム編集のための方法 |
| NZ598457A (en) | 2009-08-03 | 2014-06-27 | Recombinetics Inc | Methods and compositions for targeted gene modification |
| KR20170125406A (ko) * | 2009-08-11 | 2017-11-14 | 상가모 테라퓨틱스, 인코포레이티드 | 표적화 변형에 대한 동형접합성 유기체 |
| CA2783351C (en) | 2009-12-10 | 2021-09-07 | Regents Of The University Of Minnesota | Tal effector-mediated dna modification |
| BR112012020257A8 (pt) | 2010-02-11 | 2018-02-14 | Recombinetics Inc | métodos e aparelhos para produzir artiodátilos transgênicos |
| CA2798988C (en) * | 2010-05-17 | 2020-03-10 | Sangamo Biosciences, Inc. | Tal-effector (tale) dna-binding polypeptides and uses thereof |
-
2012
- 2012-02-24 EP EP18199895.6A patent/EP3450563A1/en not_active Withdrawn
- 2012-02-24 EP EP12749281.7A patent/EP2678434B1/en active Active
- 2012-02-24 CN CN201611151706.3A patent/CN107090470B/zh active Active
- 2012-02-24 CN CN201280020439.XA patent/CN103930550B/zh active Active
- 2012-02-24 CA CA2828239A patent/CA2828239C/en active Active
- 2012-02-24 EP EP18204730.8A patent/EP3461898A1/en not_active Withdrawn
- 2012-02-24 CN CN201611152146.3A patent/CN107058383A/zh active Pending
- 2012-02-24 AU AU2012222144A patent/AU2012222144B2/en active Active
- 2012-02-24 BR BR112013021785A patent/BR112013021785A8/pt not_active Application Discontinuation
- 2012-02-24 EA EA201391234A patent/EA201391234A1/ru unknown
- 2012-02-24 WO PCT/US2012/026500 patent/WO2012116274A2/en not_active Ceased
- 2012-02-24 JP JP2013555596A patent/JP2014509195A/ja active Pending
- 2012-02-24 US US13/404,662 patent/US20120222143A1/en not_active Abandoned
- 2012-02-24 MX MX2013009725A patent/MX363013B/es unknown
- 2012-02-24 KR KR1020137025161A patent/KR20140046408A/ko not_active Ceased
- 2012-02-24 CN CN201610545840.5A patent/CN106417184A/zh active Pending
- 2012-02-28 AR ARP120100647A patent/AR085507A1/es not_active Application Discontinuation
- 2012-08-24 US US13/594,694 patent/US20130117870A1/en not_active Abandoned
-
2013
- 2013-08-23 CL CL2013002438A patent/CL2013002438A1/es unknown
- 2013-08-23 MX MX2019002482A patent/MX2019002482A/es unknown
-
2014
- 2014-08-15 US US14/460,841 patent/US20140351965A1/en not_active Abandoned
-
2017
- 2017-04-11 AU AU2017202379A patent/AU2017202379B2/en active Active
- 2017-05-09 JP JP2017093111A patent/JP2017184744A/ja active Pending
- 2017-05-09 JP JP2017093110A patent/JP2017184743A/ja active Pending
-
2019
- 2019-08-23 JP JP2019152894A patent/JP2020010692A/ja active Pending
- 2019-11-14 AU AU2019264610A patent/AU2019264610A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014509195A5 (enExample) | ||
| EP2493288B1 (en) | Homologous recombination in the oocyte | |
| AU2011263855B2 (en) | Fusion proteins comprising a DNA-binding domain of a Tal effector protein and a non-specific cleavage domain of a restriction nuclease and their use | |
| AU2017202379B2 (en) | Gene edited livestock animals and methods of making the same | |
| JP6700306B2 (ja) | 受精前の卵細胞、受精卵、及び標的遺伝子の改変方法 | |
| RU2771532C2 (ru) | Способы и композиции для нацеленных генетических модификаций и способы их применения | |
| JP2015519923A5 (enExample) | ||
| US20200029538A1 (en) | Genome editing method | |
| US20190223417A1 (en) | Genetically modified animals having increased heat tolerance | |
| WO2025126797A1 (ja) | 高効率な長鎖核酸配列の部位特異的ノックイン法 | |
| HK1243127A1 (en) | Genetically modified animals and methods for making the same | |
| HK1233854A (en) | Genetically modified animals and methods for making the same | |
| NZ615712B2 (en) | Genetically modified animals and methods for making the same | |
| NZ712483B2 (en) | Genetically modified animals and methods for making the same | |
| NZ717891B2 (en) | Genetically modified animals and methods for making the same |